using the ventrogluteal site for intramuscular injections
A&S Science Previous     Next

using the ventrogluteal site for intramuscular injections

Kathleen Greenway Senior Lecturer in Adult Nursing, Oxford Brookes University, Oxford
Clair Merriman Senior Lecturer in Clinical Skills, Oxford Brookes University, Oxford
Diane Statham Lecturer Practitioner in Learning Disability Nursing, Oxford Brookes University, Oxford

In this article, Kathleen Greenway, Clair Merriman and Diane Statham explore the role of the learning disability practitioner in administering intramuscular injections and the evidence base supporting the use of the ventrogluteal site. The professional issues facing learning disability practitioners in relation to topics such as rapid tranquillisation, physical interventions and consent are also discussed

The ideal site for administering intramuscular (IM) injections has been discussed in a number of recently published articles (Nisbet 2006, Greenway 2004, Small 2004). These authors consider the evidence that the traditional dorsogluteal (DG) (upper outer quadrant) should be avoided for most drugs; Greenway (2004) and Small (2004) suggest that the ventrogluteal site (VG) is the site of choice for IM injections.

Learning Disability Practice. 9, 8,34-37. doi: 10.7748/ldp2006.10.9.8.34.c7672

You need a subscription to read the full article